Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation
Amyotrophic lateral sclerosis (ALS) is a devastating disease caused by degeneration of
motor neurons. As with all major neurodegenerative disorders, development of disease …
motor neurons. As with all major neurodegenerative disorders, development of disease …
Biomarkers: Promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases
A Bodaghi, N Fattahi, A Ramazani - Heliyon, 2023 - cell.com
The use of biomarkers as early warning systems in the evaluation of disease risk has
increased markedly in the last decade. Biomarkers are indicators of typical biological …
increased markedly in the last decade. Biomarkers are indicators of typical biological …
Biomarkers in stress related diseases/disorders: diagnostic, prognostic, and therapeutic values
Various internal and external factors negatively affect the homeostatic equilibrium of
organisms at the molecular to the whole-body level, inducing the so-called state of stress …
organisms at the molecular to the whole-body level, inducing the so-called state of stress …
Nearly 30 years of animal models to study amyotrophic lateral sclerosis: a historical overview and future perspectives
T Bonifacino, RA Zerbo, M Balbi, C Torazza… - International journal of …, 2021 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a fatal, multigenic, multifactorial, and non-cell
autonomous neurodegenerative disease characterized by upper and lower motor neuron …
autonomous neurodegenerative disease characterized by upper and lower motor neuron …
Blood biomarkers in ALS: challenges, applications and novel frontiers
E Sturmey, A Malaspina - Acta Neurologica Scandinavica, 2022 - Wiley Online Library
Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease among
adults. With diagnosis reached relatively late into the disease process, extensive motor cell …
adults. With diagnosis reached relatively late into the disease process, extensive motor cell …
Mitochondrial dysfunction in Alzheimer's disease: a biomarker of the future?
Alzheimer's disease (AD) is the most common cause of dementia worldwide and is
characterised pathologically by the accumulation of amyloid beta and tau protein …
characterised pathologically by the accumulation of amyloid beta and tau protein …
Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers
E Zucchi, V Bonetto, G Sorarù, I Martinelli… - Molecular …, 2020 - Springer
Motor neuron diseases (MNDs) are etiologically and biologically heterogeneous diseases.
The pathobiology of motor neuron degeneration is still largely unknown, and no effective …
The pathobiology of motor neuron degeneration is still largely unknown, and no effective …
Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis
I Magen, NS Yacovzada, E Yanowski… - Nature …, 2021 - nature.com
Amyotrophic lateral sclerosis (ALS) is a relentless neurodegenerative disease of the human
motor neuron system, where variability in progression rate limits clinical trial efficacy …
motor neuron system, where variability in progression rate limits clinical trial efficacy …
Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective
C Wong, M Stavrou, E Elliott, JM Gregory… - Brain …, 2021 - academic.oup.com
Amyotrophic lateral sclerosis is a progressive and devastating neurodegenerative disease.
Despite decades of clinical trials, effective disease-modifying drugs remain scarce. To …
Despite decades of clinical trials, effective disease-modifying drugs remain scarce. To …
Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis
H Ilieva, M Vullaganti, J Kwan - bmj, 2023 - bmj.com
Although the past two decades have produced exciting discoveries in the genetics and
pathology of amyotrophic lateral sclerosis (ALS), progress in developing an effective therapy …
pathology of amyotrophic lateral sclerosis (ALS), progress in developing an effective therapy …